Rapport Therapeutics Statistics

Total Valuation

RAPP has a market cap or net worth of $569.37 million. The enterprise value is $320.78 million.

Market Cap	569.37M
Enterprise Value	320.78M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

RAPP has 36.50 million shares outstanding. The number of shares has increased by 784.65% in one year.

Current Share Class	36.50M
Shares Outstanding	36.50M
Shares Change (YoY)	+784.65%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	6.24%
Owned by Institutions (%)	55.76%
Float	14.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.16
P/TBV Ratio	2.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.75, with a Debt / Equity ratio of 0.05.

Current Ratio	22.75
Quick Ratio	21.92
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.42% and return on invested capital (ROIC) is -20.71%.

Return on Equity (ROE)	-29.42%
Return on Assets (ROA)	-20.14%
Return on Invested Capital (ROIC)	-20.71%
Return on Capital Employed (ROCE)	-37.19%
Revenue Per Employee	n/a
Profits Per Employee	-$1.28M
Employee Count	69
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.50%
50-Day Moving Average	13.47
200-Day Moving Average	14.57
Relative Strength Index (RSI)	58.03
Average Volume (20 Days)	167,086

Short Selling Information

The latest short interest is 3.05 million, so 8.36% of the outstanding shares have been sold short.

Short Interest	3.05M
Short Previous Month	2.86M
Short % of Shares Out	8.36%
Short % of Float	20.41%
Short Ratio (days to cover)	18.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-101.77M
Pretax Income	n/a
Net Income	-88.31M
EBITDA	-100.79M
EBIT	-101.77M
Earnings Per Share (EPS)	-$2.51

Full Income Statement

Balance Sheet

The company has $260.45 million in cash and $11.86 million in debt, giving a net cash position of $248.58 million or $6.81 per share.

Cash & Cash Equivalents	260.45M
Total Debt	11.86M
Net Cash	248.58M
Net Cash Per Share	$6.81
Equity (Book Value)	263.51M
Book Value Per Share	7.22
Working Capital	258.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$76.17 million and capital expenditures -$679,000, giving a free cash flow of -$76.85 million.

Operating Cash Flow	-76.17M
Capital Expenditures	-679,000
Free Cash Flow	-76.85M
FCF Per Share	-$2.11

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-784.65%
Shareholder Yield	-784.65%
Earnings Yield	-15.51%
FCF Yield	-13.50%

Analyst Forecast

The average price target for RAPP is $33.67, which is 115.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.67
Price Target Difference	115.56%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1